Which targeted pill works best for this rare lung cancer mutation?
Disease control
Not yet recruiting
This study compares two types of targeted therapy pills (first-generation vs third-generation EGFR TKIs) for people with advanced lung cancer that has a rare EGFR mutation called 19delins. About 94 participants will be randomly assigned to one of the two treatments to see which o…
Phase: EARLY_PHASE1 • Sponsor: Fuzhou General Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC